INS and Alzheimer disease: Different classes of anti-diabetic medications, including intranasal insulin, glucagon-like peptide receptor agonists, biguanides, thiazolidinediones, and dipeptidyl peptidase-4 inhibitors, have been shown to improve memory and reduce neuroinflammation and oxidative stress in AD patients [25, 26].